Targeted chemo-photothermal therapy in breast cancer cells by using doxorubicin loaded albumin modified nanoparticles
Barbara Carrese a, Chiara Cavallini b, Gennaro Sanità c, Paolo Armanetti b, Brigida Silvestri d, Walter Michele Alotti a, Giulio Pota d, Giuseppina Luciani d, Luca Menichetti b, Annalisa Lamberti a
a Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
b Institute of Clinical Physiology, National Research Council, Pisa, Italy
c Institute of Applied Sciences and Intelligent Systems, National Research Council, Naples, Italy
d Department of Chemical, Materials and Production Engineering, University of Naples Federico II, Naples, Italy
Proceedings of Advanced materials and devices for nanomedicine (AMA4MED)
VALÈNCIA, Spain, 2022 May 3rd - 4th
Organizers: Claudia Tortiglione and María Moros
Poster, Barbara Carrese, 005
Publication date: 22nd April 2022
ePoster: 

Nanotheranostic is an encouraging strategy to perform in tumors targeted diagnosis and therapy. This approach is based on the use of particles with nanoscale size (nanoparticles, NPs) as carriers for contrast agents (CAs) and drugs.

In our previous studies, photoacoustic (PA) properties of hybrid NPs (MelaSil_Ag), composed of a metallic silver clustered in a silicon and melanin like compound shell functionalized with Human Serum Albumin (HSA), were tested.

In this study, MelaSil_Ag NPs were loaded with DOX (MelaSil_Ag-HSA@DOX) to assess their chemothermal therapy efficiency. Data showed that DOX loaded-NPs is more effective with the tested breast cancer cell line, compared to the free drug under the same experimental conditions, allowing the use of lower drug concentrations and time exposure. This effect is probably due to the combination of targeted delivery with the overcoming of multidrug resistance.

Next, the cytotoxic effect of the DOX-loaded NPs followed by laser irradiation at 808 nm to induce photothermal phenomena in NPs was investigated. After 6h of treatment at the lowest concentration, the synergistic effect of temperature increases and DOX toxicity, associated to the improved drug release after photothermal heating, produces a relatively higher cytotoxicity compared to dark conditions.

All together, our results confirm that photothermal therapy (PTT) improves the therapeutic effect of MelaSil_Ag-HSA@DOX NPs. In conclusion, the use of DOX loaded NPs, thanks to chemo- and photothermal approaches, allows the reduction of DOX effective concentration and time exposure.

© FUNDACIO DE LA COMUNITAT VALENCIANA SCITO
We use our own and third party cookies for analysing and measuring usage of our website to improve our services. If you continue browsing, we consider accepting its use. You can check our Cookies Policy in which you will also find how to configure your web browser for the use of cookies. More info